Metraipolis › archive › dc_a0750b047ca3

Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes — Europe PMC PMID:42180536

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180536
DOI
10.1016/j.apsb.2026.01.035
License (as archived)
solo-consultazione
Archived
2026-11-06T09:40:02.299Z
SHA-256 of the archived text
8478e0159a8fd0ec1d045842fbb694496ea1b76a835c68008d924fca23c844c9
Stable URL of this page
https://metraipolis.com/documento/dc_a0750b047ca3

How to cite

Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes — Europe PMC PMID:42180536 — Europe PMC (en), https://europepmc.org/article/MED/42180536 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a0750b047ca3 (Metraipolis archive dc_a0750b047ca3, sha256 8478e0159a8fd0ec1d045842fbb694496ea1b76a835c68008d924fca23c844c9)
BibTeX
@misc{dca0750b047ca3,
  title = {Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes — Europe PMC PMID:42180536},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180536},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a0750b047ca3; sha256 8478e0159a8fd0ec1d045842fbb694496ea1b76a835c68008d924fca23c844c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180536. Agents can read the archived copy with the MCP tool read_document.